It's the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to reduce costs and shorten the time it ...

The draft guidance, which is touted as a way to reduce the cost and time-associated burden of biosimilar development, has ...

There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...

CHENNAI: The researchers from Indian Institute of Technology Madras and The Ohio State University, US, have developed a breakthrough Artificial Intelligence (AI ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...

POTOMAC, MARYLAND / ACCESS Newswire / / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a ...

So far, the USFDA has approved 76 biosimilars but the market share of these remains below 20% with only 10% of the biologics ...

The United States has said it will speed up approval for some generic drugs. The development comes weeks after it was ...

Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...

Sai Life Sciences announces the groundbreaking of a state-of-the-art CMC Process R&D Center in Hyderabad, poised to double ...

Company highlights its global expertise and new and expanded capabilities to help biopharma and biotech customers solve global health challenges Thermo Fisher Scientific Inc., the world leader in ...